Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Residual Disease From Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer Following Surgery and Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a monoclonal antibody therapy in patients with residual disease after surgery and chemotherapy for stage III/IV ovarian cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Unspecified monoclonal antibody therapy

Snippet

Sponsor: AltaRex | Conditions: Fallopian Tube Cancer, Ovarian Cancer | Phase 2 | Status: UNKNOWN